eczema biologics

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of Asia’s fuel crisis deepening as the Philippines declares an energy emergency after Strait of Hormuz shipping disruptions raised fears over regional oil supply and fuel availability.

Asia’s fuel crisis deepens: Philippines declares emergency as Strait of Hormuz shipping collapses

Eve Air Mobility (NYSE: EVEX) flies its eVTOL prototype for Brazilian authorities as certification work moves from concept to execution

Eve Air Mobility just flew its eVTOL for Brazil’s top officials. Is this the moment the air taxi race gets real?

Representative image of a leukemia drug development and biopharma acquisition theme, illustrating why Merck’s $6.7bn Terns Pharmaceuticals deal and TERN-701 are drawing attention as the Keytruda patent cliff approaches.

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Representative image of an Infosys office building, reflecting the firm’s global push to scale Topaz as a full-stack generative AI transformation platform.

Why is Infosys buying Stratus now as insurance platform modernization enters an AI-heavy phase?

What rademikibart Phase 3 data could mean for Connect Biopharma’s immunology strategy (NASDAQ: CNTB)

Connect Biopharma’s rademikibart Phase 3 eczema data will debut at AAD 2026. Discover what it means for biologic competition and Connect Biopharma strategy.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 13, 2026